UK markets close in 5 hours 38 minutes

Biotest Aktiengesellschaft (0N6Z.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
42.60-0.40 (-0.92%)
As of 09:02AM BST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.24
52-week change 3N/A
S&P500 52-week change 324.16%
52-week high 30.00
52-week low 30.00
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 539.57M
Implied shares outstanding 6N/A
Float 820.5M
% held by insiders 197.14%
% held by institutions 10.21%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.04
Trailing annual dividend yield 30.09%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 22.60%
Operating margin (ttm)24.54%

Management effectiveness

Return on assets (ttm)8.47%
Return on equity (ttm)40.25%

Income statement

Revenue (ttm)782.6M
Revenue per share (ttm)19.61
Quarterly revenue growth (yoy)83.60%
Gross profit (ttm)N/A
EBITDA 208.95M
Net income avi to common (ttm)176.9M
Diluted EPS (ttm)-1.37
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)84.7M
Total cash per share (mrq)2.12
Total debt (mrq)693.2M
Total debt/equity (mrq)131.31%
Current ratio (mrq)2.04
Book value per share (mrq)13.24

Cash flow statement

Operating cash flow (ttm)23M
Levered free cash flow (ttm)-60.54M